What’s the current market cap for Community Healthcare Trust stock?

Community Healthcare Trust (CHCT) has a market cap of $471m as of June 18, 2026.

What is the P/E ratio for Community Healthcare Trust stock?

The price to earnings (P/E) ratio for Community Healthcare Trust (CHCT) stock is 155.42 as of June 18, 2026.

Does Community Healthcare Trust stock pay dividends?

Yes, the Community Healthcare Trust (CHCT) stock pays dividends to shareholders. As of June 18, 2026, the dividend rate is $1.905 and the yield is 11.01%. Community Healthcare Trust has a payout ratio of 892.49% on a trailing twelve-month basis.

When is the next Community Healthcare Trust dividend payment date?

The next Community Healthcare Trust (CHCT) dividend payment date is unconfirmed.

What is the beta indicator for Community Healthcare Trust?

Community Healthcare Trust (CHCT) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Community Healthcare Trust stock | $CHCT Share Price

13:30

15:10

16:45

18:25

20:00

About Community Healthcare Trust

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

Ticker

$CHCT

Sector

Real Estate

Primary listing

NYSE

Employees

Headquarters

Franklin, United States

Website

www.chct.reit

CHCT Metrics

BasicAdvanced

$471m

155.42

$0.11

0.71

$1.91

11.01%

Bulls say / Bears say

Q1 2026 revenue grew 4.8% YoY to $31.52 M, surpassing expectations and reflecting resilient demand for healthcare real estate. (Reuters)

Board approved its 43rd consecutive quarterly dividend increase to $0.48 per share, underscoring management’s commitment to shareholder returns. (Reuters)

No single tenant represents more than 7.1% of annualized revenue, reducing counterparty concentration risk across its diversified portfolio. (Reuters)

Q1 2026 EPS of $0.07 missed the consensus $0.10 forecast by 30%, highlighting bottom-line volatility. (Reuters)

Management noted a more challenging acquisition environment, with annual investments declining to $28.5 M YTD from $152 M in 2019, potentially constraining portfolio growth. (Reuters)

Debt-to-gross real estate value increased to 44.9% in Q1 2026 from 42.5% a year ago, raising leverage and interest-rate exposure concerns. (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 3 Jun 2026.

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.